Search Main Menu Main Content
  • Change contrast :
Haute Autorité de Santé
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

  • No element in selection

  • Contact

1 result

  • Topics : Contraception, abortion and sterilization
  • Active substance : misoprostol
  • Type : Practice Guidelines and Other Guides
Filter
Topic
  • Diseases and conditions (1)
  • Plus ...
    • Pregnancy and reproduction (1)
    • Plus ...
      • Contraception, abortion and sterilization (1)
Content type
  • Practice Guidelines and Other Guides (1)
  • Plus ...
    • Practice guidelines (1)
Language
  • Français (1)
Active substance
  • ceftriaxone (1)
  • dinoprostone (1)
  • doxycycline (1)
  • fentanyl (1)
  • fer (1)
  • halothane (1)
  • isoflurane (1)
  • midazolam (1)
  • misoprostol (1)
  • morphine (1)
  • propofol (1)
  • sufentanil (1)
  • sulprostone (1)
  • trinitrine (1)

Practice Guidelines and Other Guides

  • « Première page
  • < Page précédente
  • / 1
  • > Page suivante
  • » Dernière page
Sorted by :Relevance
  • Title
  • Date

  • Induced abortion up to 14 weeks

    Practice guidelines - Posted on 01/03/2001
    Add to my selection
  • « Première page
  • < Page précédente
  • / 1
  • > Page suivante
  • » Dernière page
  • 10 par pages
    • 10 par pages
    • 20 par pages
    • 50 par pages
    • 100 par pages
Haute Autorité de Santé
Advancing quality in the fields of health and social care services

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • fr Français
  • en English
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
njBkRE6hNzdL4RcW